Cite
HARVARD Citation
Gong, J. et al. (n.d.). 810 Preliminary safety, tolerability and efficacy results of KN026 in combination with KN046 in patients with HER2 aberrated solid tumors. Journal for immunotherapy of cancer. pp. A485-A486. [Online].